Prediction of outcomes in MCI with 123I-IMP-CBF SPECT: a multicenter prospective cohort study
Kengo Ito(National Center for Geriatrics and Gerontology), Kenichi Meguro(Tohoku University), Etsuro Mori(The University of Osaka), Seigo Nakano(Oida Hospital), Jun Hatazawa(Osaka University of Pharmaceutical Sciences), Haruo Hanyu(Tokyo Medical University), Kazuo Hashikawa(Kyoto University), Shin Kitamura(Nippon Medical School Musashi Kosugi Hospital), Toshimitsu Momose, Hiroshi Matsuda(Kawamura Gakuen Women's University), Hidenao Fukuyama(Chinese Academy of Sciences), Kazunari Ishii(Hyogo Brain and Heart Center), Yoshiharu Yonekura(State University of New York), Kenji Kosaka(Kamiichi General Hospital), Yoshitaka Uchida(Chiba University), Takashi Asada(University of Tsukuba), Tatsuo Yamada(Fukuoka University), Satoru Mori(University of Shiga Prefecture), Yasuo Kuwabara(Fukuoka University Hospital), Satoshi Minoshima(University of Utah), Yukihiko Washimi(National Center for Geriatrics and Gerontology)
Cited by 33
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET
|NeuroImage|2002|839
Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus: Second Edition
|Neurologia medico-chirurgica|2012|670
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
|The Lancet Neurology|2020|535